Shire plc (SHPG) to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
5/17/2013 8:36:50 AM
More...
|
Forest Laboratories, Inc. (FRX) to Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychiatric Association Annual Meeting
5/16/2013 11:29:31 AM
More...
|
Titan Pharmaceuticals (TTP)' Probuphine Program to be Presented at ASAM Medical-Scientific Conference and American Psychiatric Association Annual Meeting
4/22/2013 12:25:07 PM
More...
|
Lightlake Therapeutics Inc. (LLTP) Announces Phase II Clinical Trial Results of Treatment for Binge Eating Disorder Accepted at the American Psychiatric Association Annual Meeting
3/27/2013 11:15:20 AM
More...
|
UMass Boston Researcher Raises Questions on Validity and Trustworthiness of American Psychiatric Association Clinical Guidelines
3/20/2013 3:01:28 PM
More...
|
Internet Addiction is the New Mental Health Disorder, American Psychiatric Association Reveals
10/3/2012 7:22:30 AM
More...
|
Purdue Pharma L.P. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo(R) (zolpidem tartrate) Sublingual Tablets CIV
5/8/2012 11:45:20 AM
More...
|
Otsuka Pharmaceutical Co., Ltd. Release: Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM) Depot Formulation for the Maintenance Treatment of Schizophrenia Presented at American Psychiatric Association Annual Meeting
5/7/2012 9:44:43 AM
More...
|
Shire plc to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
5/4/2012 11:48:27 AM
More...
|
Forest Laboratories, Inc. (FRX) to Present Cariprazine and Levomilnacipran Results from Phase 3 Trials at American Psychiatric Association Annual Meeting
5/4/2012 10:04:27 AM
More...
|
|